23 results were returned
In the third of our series of articles written by members of our International Trade Secrets Group, and intended to highlight particular points to note relating to the protection of Trade Secrets in various different ...
Belgium has a strategic location situated in the heart of Europe and hosts a significant number of international organisations and institutions, such as the European Union and NATO. Belgium is a welcoming environment ...
On 25 July 2018, the European Court of Justice ("ECJ" or the "Court") rendered judgment in the Mitsubishi case (C-129/17) on the issues of de-branding and subsequent re-branding of goods imported into the EU.
With our substantial experience in advising some of the world's largest medtech, biotech and pharmaceutical companies, our Medical Devices Group is uniquely placed to offer specific and strategic solutions.
In this article, we touch upon the favorable IP regime, which, provides for specific research exemptions under patent law.
The long-awaited Regulation (EU) 2018/302 (the "Geo-blocking Regulation") entered into force on 3 December 2018. Six months later, Belgium has taken the necessary steps to implement its enforcement obligations.
Our practice is built on the belief that it is important to understand the scientific, ethical and business challenges facing companies in the sector to provide practical and commercially viable advice for our clients